ATTIVITA’ FORMATIVA
+) Diploma di Laurea in Medicina e Chirurgia c/o la Facoltà di Medicina e Chirurgia dell’Università degli
Studi di Parma
+) Diploma di Specializzazione in Psichiatria c/o l’Istituto di Clinica Psichiatrica della Facoltà di Medicina
e Chirurgia dell’ Università degli Studi di Parma
+) Diploma di Laurea Magistrale in Psicologia dello Sviluppo c/o la Facoltà di Psicologia dell’ Università
degli Studi d i Parma
+) Dottorato di Ricerca in “Neuroscienze clinico sperimentali e Psichiatria curriculum: intervento precoce
negli esordi psicotici e nei disturbi dell’umore ” c/o la Facoltà di Medicina e Chirurgia (Dipartimento di
Neuroscienze) dell’Università degli Studi “La Sapienza” di Roma
+) Ottobre 2022-Ottobre 2025 - Ricercatore a tempo determinato in Psichiatria ” c/o il Dipartimento di Scienze Biomediche e Neuromotorie dell’Università degli Studi di Bologna.
+) Ottobre 2025 ad oggi - Professore Associato (II fascia) in psichiatria c/o il Dipartimento di Scienze Biomediche e Neuromotorie dell’Università degli Studi di Bologna.
ATTIVITA’ PROFESSIONALE
+) Dirigente medico di psichiatria a tempo determinato pe r l’Azienda Ospedaliera “Istituti Ospitalieri” di
Cremona servizio svolto presso l’ SPDC del presidio ospedaliero “Oglio Po” di Casalmaggiore (CR);
+) Dirigente medico di psichiatria a tempo indeterminato per l’AUSL IRCCS di Reggio Emilia (RE),
servizio svolto c/o il CSM di Guastalla (RE) e il CSM “Via Petrella” di Reggio Emilia (RE), di cui sono stato
responsabile di unità operativa semplice;
+) Dirigente medico di psichiatria a tempo indeterminato p er l’AUSL di Parma PR servizio svolto c/o la
RTI “Santi” di Parma, la RTE “I Maggio” di Colorno la REMS di Parma e negli Istituti Penitenziari di
Parma, di cui sono stato responsabile dell’unità operativa semplice.
+) Dal 2016, membro del gruppo tecnico regionale “ Esordi Psicotici ” della Regione Emilia Romagna.
+) Ottobre 2022-Ottobre 2025: Ricercatore a tempo determinato in Psichiatria presso il Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM) dell’Alma Mater Studiorum Università degli Studi di
Bologna, con convenzione all’attività clinica presso l’AUSL di Bologna servizio svolto presso il CSM
“Saragozza” di Bologna e l’RTI “Arcipelago” di Bologna
+) Ottobre 2025 ad oggi: Professore Associato (II fascia) in psichiatria c/o il Dipartimento di Scienze Biomediche e Neuromotorie dell’Università degli Studi di Bologna, con convenzione all’attività clinica presso l’AUSL di Bologna servizio svolto presso il CSM “Saragozza” di Bologna e l’RTI “Arcipelago” di Bologna.
PUBBLICAZIONI SCIENTIFICHE (ultimi 2 anni)
Alfieri M,…,Pelizza L, Menchetti M. “Dissociation and dysfunctional personality traits in patients with borderline personality disorder: a study based on DSM-5 alternative model”. The European Journal of Psychiatry 2025; 39: 100283. https://doi.org/10.1016/j.ejpsy.2024.100283.
Pelizza L, et al. “Baseline exposure to antipsychotic medication in young people at clinical high risk for psychosis: a 2-year Italian follow-up study”. Human Psychopharmacology: clinical and experimental 2025; 40: e70003. https://doi.org/10.1002/hup.70003.
Pelizza L, et al. “Sex comparisons on the beneficial effects of an early intervention program in a patients’ cohort with first episode psychosis: what effectiveness in women?” Archives of Women’s Mental Health 2025; https://doi.org/10.1007/s00737-025-01566-1.
Pelizza L, et al. “Psychiatric antecedents in young patients with first episode psychosis: what relevance for clinical outcomes?”. European Archives of Psychiatry and Clinical Neuroscience 2025; February 28th. https://doi.org/10.1007/s00406-025-01981-6.
Pellegrini P,…,Pelizza L. “Suggestions on early psychosis: towards a new psychopathology?”. Academia Mental Health & Well-Being 2025; 2: 1-8. https://doi.org/10.20935/MHealthWellB7584.
Pelizza L, et al. “What autism in first episode psychosis? Results from a 2-year follow-up study”. European Archives of Psychiatry and Clinical Neuroscience 2025; March 5th. https://doi.org/10.1007/s00406-025-01986-1.
Pelizza L, et al. “Compulsory treatment across 2-year follow-up within an “Early Intervention in Psychosis” program in Italy: incidence rate and baseline predictors”. Schizophrenia Research 2025; 279: 1-12. https://doi.org/10.1016/j.schres.2025.03.028.
Pelizza L, et al. “Compulsory admission as access to early intervention service for patients with first episode psychosis: what relevance for clinical outcomes? Further findings from the Pr-EP program”. Psychiatry Research 2025; 349: 116507. https://doi.org/10.1016/j.psychres.2025.116507.
Pelizza L, et al. “Autism characteristics in young patients with first episode of schizophrenia spectrum disorder: findings from a 2-year longitudinal research”. Journal of Psychiatric Research 2025; 186: 407-425. https://doi.org/10.1016/j.jpsychires.2025.04.041.
Merola GP, Patti A, Catania G, Baccaredda Boy O, …, Pelizza L, …, Ricca V. “Phenomenological psychopathology meets machine learning: a multicentric retrospective study (Mu.St.A.R.D.) targeting the role of aberrant salience assessment in psychosis detection”. Schizophrenia Research 2025; 281: 147-156. https://doi.org/10.1016/j.schres.2025.04.028.
Martinelli A, Leone S, …, Pelizza L, et al. “Sex differences in schizophrenia spectrum disorders: insights from the DiAPAson study using a data-driven approach”. Social Psychiatry and Psychiatric Epidemiology 2025; https://doi.org/10.1007/s00127-025-02855-x.
Baldini V, Pasquino F, ..., Pelizza L, Menchetti M. “Sleep disturbances in individuials with first episode psychosis and clinical high-risk states: a systematic review”. Schizophrenia Research 2025; 282: 123-132. https://doi.org/10.1016/j.schres.2025.06.008.
Pelizza L, et al. “Suicidality in youths at clinical high risk for psychosis: a neglected public health concern”. European Child and Adolescent Psychiatry 2025; https://doi.org/10.1007/s00787-025-02798-3.
Pelizza L, et al. “Autism-spectrum traits in First Episode Psychosis: psychopathological and prognostic considerations from a 2-year follow-up study”. Schizophrenia Research 2025; 283: 163-172. https://doi.org/10.1016/j.schres.2025.07.014.
Pelizza L, Pupo S. “Towards a name change of schizophrenia: is it really necessary?” European Archives of Psychiatry and Clinical Neuroscience 2025; https://doi.org/10.1007/s00406-025-02105-w.
Pelizza L, et al. “Mental health antecedents in first episode psychosis: impact on prognosis across transitional age”. European Child and Adolescent Psychiatry 2025; https://doi.org/10.1007/s00787-025-02880-w.
Pelizza L, et al. “What does the PANSS Autism Severity Score (PAUSS) really measure in patients with first episode psychosis? Critical considerations”. Journal of Autism and Developmental Disorders 2026; https://doi.org/10.1007/s10803-025-07197-w.
Pelizza L, et al. “Comorbid major psychopathology in chronic pain: a neglected clinical condition? Preliminary, descriptive results from the P3 study”. Journal of Psychopathology 2025; 31: 182-190. https://doi.org/10.36148/2284-0249-1588.
Pellegrini P, Leuci E, …, Pelizza L. “The Italian 2023 mental health report: a comment”. Journal of Psychopathology 2025; 31: 191-195. https://doi.org/10.36148/2284-0249-1596.
Pelizza L, et al. “Early intervention in psychosis: perceptions, strengths, criticalities, and improvement proposals from the perspective of Italian mental healthcare professionals”. Community Mental Health Journal 2026; https://doi.org/10.1007/s10597-025-01575-5.
Pelizza L, et al. “Comorbid DSM-5 mental disorders and chronic pain: what kind of relationship? Findings from the P3 cross-sectional study”. Journal of Psychosomatic Research 2026; https://doi.org/10.1016/j.jpsychores.2026.112549.
Pelizza L, et al. “A music therapy group intervention in an Italian prison: the subjective impact of a pilot program”. The Arts in Psychotherapy 2026; 98: 102434. https://doi.org/10.1016/j.aip.2026.102434.
Baldini V, Iannucci F, …, Pelizza L, Menchetti M. “Sleep in early psychosis: preliminary results on actigraphic and self-reported markers of vulnerability”. Early Intervention in Psychiatry 2026; 20: e70160. https://doi.org/10.1111/eip.70160.
Pelizza L, et al. “Exposure to antipsychotics in youths at Clinical High Risk for psychosis: low vs high doses and their relevance for clinical outcomes”. Early Intervention in Psychiatry 2026; 20: e70167. https://doi.org/10.1111/eip.70167.
Pelizza L, et al. “Clinical factors influencing improvement in disorganization in clinical high risk for psychosis: preliminary findings from a 2-year follow-up”. Asia-Pacific Psychiatry 2026; 18:e70021. https://doi.org/10.1111/appy.70021.
Pelizza L, et al. “What psychiatric comorbidity in chronic pain? New insights for an old, underestimated issue”. Minerva Psychiatry 2026; 67. https://doi.org/10.23736/S2724-6612.26.02679-5.
Doroldi D, Origlia G, …, Pelizza L, Ciocca G. “Is problematic sexuality a marker for the onset of mental disorders? A cross-sectional study on psychotic-like experiences and sexual behaviour in a non-clinical sample”. Journal of Psychiatric Research 2026; 200: 63-70. https://doi.org/10.1016/j.jpsychires.2026.05.026.
Pelizza L, et al. “Sex-specific clinical profiles and long-term outcomes in adolescents and young people at clinical high risk for psychosis: findings from the PARMS program. European Child and Adolecent Psychiatry 2026; https://doi.org/10.1007/s00787-026-03082-8.
